Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | PDE9A | O76083 | 1/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19547607 | 0.98 | GSTP1 (0.48) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL25634493 | 0.94 | HDAC4 (0.49) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL29350362 | 0.91 | ESR1 (0.52) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL2379728 | 0.91 | ESR1 (0.52) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL36279 | 0.91 | ESR1 (0.52) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL536536 | 0.90 | PIM1 (0.47) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL29350427 | 0.90 | PIM1 (0.47) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL15366918 | 0.89 | ESR1 (0.43) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL26750845 | 0.89 | GSTP1 (0.42) | GSTP1HDAC4HDAC2HDAC8ESR1 | |
| SCHEMBL25060858 | 0.89 | ESR1 (0.50) | GSTP1HDAC4HDAC2HDAC8ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180596-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| EP-1957606-B1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINIESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-11-08 | — | — | EP | disclosed |
| US-9017825-B2 | Anthracene derivatives and their use in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-04-28 | — | — | US | disclosed |
| US-20080303423-A1 | Novel Materials For Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-12-11 | — | — | US | disclosed |
| EP-1957606-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINIESCENT DEVICES | Merck Patent GmbH (DE) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007065678-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINIESCENT DEVICES | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180596-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | CRY1, CRY2, CYBA | GSTP1 513/4885HDAC4 4491/4885HDAC2 3003/4885 |
| US-20080303423-A1 | Novel Materials For Organic Electroluminescent Devices | ANXA2, ANXA7, ANXA1 | GSTP1 1769/4885HDAC4 3944/4885HDAC2 3289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.